These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3928777)

  • 21. Outcomes after early or midfollicular phase LH supplementation in previous inadequate responders.
    Sönmezer M; Iltemir Duvan C; Ozmen B; Taşçi T; Ozkavukçu S; Atabekoğlu CS
    Reprod Biomed Online; 2010 Mar; 20(3):350-7. PubMed ID: 20093082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T; McInnes RA; Arronet GH
    Int J Fertil; 1984; 29(2):113-7. PubMed ID: 6148315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subcutaneous long-term pulsatile administration of LH-RH to patients with hypothalamic amenorrhea].
    Mizunuma H; Obara M; Yamada K; Ibuki Y; Igarashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):933-9. PubMed ID: 3525703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the mode of clomiphene citrate administration on ovarian response in an in vitro fertilization program.
    Rönnberg L; Martikainen H; Kirkinen P
    Int J Fertil; 1988; 33(5):334-7. PubMed ID: 2904420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian response and induction of ovulation with human menopausal gonadotropin of different ratio of FSH to LH content in women with ovarian insufficiency].
    Koyama T; Kamata S; Kubota T; Ohara M; Ichimura M; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):445-51. PubMed ID: 3131463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful pregnancy following low-dose hCG administration in addition to hMG in a patient with hypothalamic amenorrhea due to weight loss.
    Tsutsumi R; Fujimoto A; Osuga Y; Harada M; Takemura Y; Koizumi M; Yano T; Taketani Y
    Gynecol Endocrinol; 2012 Jun; 28(6):460-2. PubMed ID: 22103675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of hormonal dynamics in pregnant and nonpregnant cycles during pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
    Nakamura Y; Yoshimura Y; Oda T; Shiokawa S; Yoshinaga A; Akiba M
    Fertil Steril; 1993 Aug; 60(2):254-61. PubMed ID: 8339820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovulation induction with pulsatile human menopausal gonadotropin (HMG) administration.
    Friedler S; Diamant YZ
    Eur J Obstet Gynecol Reprod Biol; 1987 Aug; 25(4):303-13. PubMed ID: 3115845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment.
    Nichols J; Knochenhauer E; Fein SH; Nardi RV; Marshall DC
    Fertil Steril; 2001 Jul; 76(1):58-66. PubMed ID: 11438320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative analysis of fertile and infertile cycles during stimulation of ovulation with pergonal in patients with hypo- gonadotropic amenorrhea].
    Manuilova IA; Sotnikova EI; Shchedrina RN; Torganova IG; Nazarenko TA; Zykin BI
    Akush Ginekol (Mosk); 1989 Oct; (10):14-8. PubMed ID: 2515765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ovulation induction with gonadotropins aided by cervix mucus analysis and echography].
    Murillo A; Ortega E; Castorena G; Ayala A; Bermúdez JA; Morán C
    Ginecol Obstet Mex; 1992 Jun; 60():181-4. PubMed ID: 1618413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Termination of early pregnancy in the rat by a single dose of human menopausal gonadotropin.
    Espey LL; Stacy S; Hayter H; Fujii S
    Early Pregnancy; 1997 Mar; 3(1):23-6. PubMed ID: 9265555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The characteristics of hypophyseal gonadotropic function in patients with hypogonadotropic amenorrhea against a background of pergonal ovulation stimulation].
    Shchedrina RN; Nazarenko TA; Durinian ER; Kiriushkin AV; Mullabaeva SM; Fanchenko ND; Sotnikova EI
    Akush Ginekol (Mosk); 1993; (4):43-5. PubMed ID: 8250118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovulation and pregnancy after pulsatile administration of gonadotropin releasing hormone.
    Berg D; Mickan H; Michael S; Döring K; Gloning K; Jänicke F; Rjosk HK
    Arch Gynecol; 1983; 233(3):205-10. PubMed ID: 6354104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinico-hormonal characteristics of patients with hypogonadotropic amenorrhea].
    Nazarenko TA
    Akush Ginekol (Mosk); 1989 Oct; (10):18-21. PubMed ID: 2515766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional state of the reproductive system in patients with the hypogonadotropic form of amenorrhea during use of various protocols of ovulation induction with human menopausal gonadotropins].
    Shchedrina RN; Nazarenko TA; Kolod'ko VG; Mullabaeva SM; Efremova LD; Kiriushkin AV
    Akush Ginekol (Mosk); 1994; (1):38-41. PubMed ID: 8209954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The course of pregnancy induced by ovulation stimulation in patients with the hypogonadotropic form of amenorrhea].
    Sotnikova EI; Chernukha EA; Nazarenko TA; Tiutiunnik VL; Zykin BI
    Akush Ginekol (Mosk); 1994; (2):14-7. PubMed ID: 8017572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration.
    Weissman A; Lurie S; Zalel Y; Goldchmit R; Shoham Z
    Gynecol Endocrinol; 1996 Aug; 10(4):273-6. PubMed ID: 8908528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.